Exclusive: TikTok sellers purporting to sell the ‘Triple G’ of weight loss jabs have had their accounts pulled after The ...

Amazon › The past five years have been rocky, to say the least. Investors have dealt with a worldwide pandemic, political ...

While Pfizer's market cap and dividends are at risk, Novo has a strong competitive position in GLP-1 TAM. Read why I prefer ...

Eli Lilly and Company (NYSE: LLY) is one of the stocks to invest in before they split next. On September 9, Eli Lilly and Company launched a new global campaign titled “Brain Health Matters” to ...

In a major strategic shift, Novo Nordisk has announced a significant workforce reduction, eliminating approximately 9,000 ...

Three Motley Fool contributors believe they've identified dividend stocks to buy in September that fall into the latter ...

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

A Seattle startup company has inked a deal with Eli Lilly to develop AI powered cancer treatments. The team at Lila Biologics ...

Regulators sent about 100 warning letters this week to drug advertisers, including to Hims & Hers, a major online provider of ...

Britain's biggest company AstraZeneca has paused a planned 200 million pound ($271.26 million) investment in its Cambridge ...

AstraZeneca has paused a £200mn Cambridge expansion, joining Merck and Eli Lilly in scaling back UK investments amid tensions ...

Many doctors are calling for the Pharmaceutical Benefits Scheme to subsidize GLP-1 agonists to increase access for patients ...